CLOFAZIMINE - A REVIEW OF ITS MEDICAL USES AND MECHANISMS OF ACTION

被引：129

作者：

ARBISER, JL

MOSCHELLA, SL

机构：

[1] HARVARD UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA

[2] LAHEY CLIN FDN,BURLINGTON,MA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1995年 / 32卷 / 02期

关键词：

D O I：

10.1016/0190-9622(95)90134-5

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Clofazimine has been in clinical use for almost 40 years, but little is known of its mechanism of action. The primary indication for clofazimine is multibacillary leprosy, but it is useful in several infectious and noninfectious diseases, such as atypical mycobacterial infections, rhinoscleroma, pyoderma gangrenosum, necrobiosis lipoidica, severe acne, pustular psoriasis, and discoid lupus erythematosus. Postulated mechanisms of action include intercalation of clofazimine with bacterial DNA and increasing levels of cellular phospholipase A2. Clinical experience, possible mechanisms of action, and side effects of clofazimine are summarized.

引用

页码：241 / 247

页数：7

共 93 条

[31] ACTIVITY OF RIFABUTIN ALONE OR IN COMBINATION WITH CLOFAZIMINE OR ETHAMBUTOL OR BOTH AGAINST ACUTE AND CHRONIC EXPERIMENTAL MYCOBACTERIUM-INTRACELLULARE INFECTIONS [J].

GANGADHARAM, PRJ ;

PERUMAL, VK ;

JAIRAM, BT ;

RAO, PN ;

NGUYEN, AK ;

FARHI, DC ;

ISEMAN, MD .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (02) :329-333

[32]

GANGADHARAM PRJ, 1977, AM REV RESPIR DIS, V115, P705

[33] INVIVO ACTIVITY OF AMIKACIN ALONE OR IN COMBINATION WITH CLOFAZIMINE OR RIFABUTIN OR BOTH AGAINST ACUTE EXPERIMENTAL MYCOBACTERIUM-AVIUM COMPLEX INFECTIONS IN BEIGE MICE [J].

GANGADHARAM, PRJ ;

PERUMAL, VK ;

PODAPATI, NR ;

KESAVALU, L ;

ISEMAN, MD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (09) :1400-1403

[34]

GANGADHARAM PRJ, 1983, AM REV RESPIR DIS, V127, P468

[35] CLOFAZIMINE - A REVIEW OF ITS USE IN LEPROSY AND MYCOBACTERIUM-AVIUM COMPLEX INFECTION [J].

GARRELTS, JC .

DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (05) :525-531

[36]

GIRDHAR A, 1992, LEPROSY REV, V63, P47

[37] TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN [J].

GOBLE, M ;

ISEMAN, MD ;

MADSEN, LA ;

WAITE, D ;

ACKERSON, L ;

HORSBURGH, CR .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :527-532

[38]

GREER KE, 1982, CLIN RHEUM DIS, V8, P427

[39]

HASTINGS RC, 1988, ANNU REV PHARMACOL, V28, P231

[40]

HELANDER I, 1987, ACTA DERM-VENEREOL, V67, P535

← 1 2 3 4 5 6 7 8 9 10 →